Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2024 Feb 8;15:1379325. doi: 10.3389/fimmu.2024.1379325

Corrigendum: Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells

Zhenyu Wei 1,*, Jiayu Xu 1, Chengkui Zhao 1,2, Min Zhang 1, Nan Xu 2,3, Liqing Kang 2,3, Xiaoyan Lou 2,3, Lei Yu 2,3,*, Weixing Feng 1,*
PMCID: PMC10852047  PMID: 38333207

In the published article, there was an error in Supplementary and the names of the patients were erroneously included. The names have been removed from the supplementary materials to protect the anonymity and identity of the patients.

The supplementary material has been updated in the original article.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES